Where AI Creates Value in Drug Discovery

Live Webinar | October 13 at 2pm ET | AI promises to transform drug discovery, cutting failure rates by 20% and saving as much as $1 billion for each new therapy that reaches patients.

But with most AI projects still in the pilot phase, the gap between what AI might do and the measurable value it currently produces seems especially wide.

How can biopharmaceutical leaders identify investments in AI that will pay off and ones that won’t? In this webinar, leaders from companies across the AI value chain lead a candid conversation about what’s working in AI-driven drug discovery, what isn’t, and why. They’ll share lessons learned from real-world experiences, offer actionable advice about how to prepare for the industry’s future, and explain:

Where AI is delivering measurable ROI in drug discovery today, and where its promise remains unrealized
Best practices for scaling AI projects from pilot to production
How to maximize the value of generative models, AI agents and agent skills

FILL THE FORM BELOW

First Name *

Last Name *

Company Street Address *

Company Suite/Office *

Company Postal/Zip Code *

Company City *

Company State *

Company Country *

By submitting this content request, I have legitimate interest in the content and agree that BioPharma Dive's Studio by Informa TechTarget and Nebius, their partners, and the creators of any other content I have selected may contact me regarding news, products, and services that may be of interest to me.

YesNo

By completing this form, you accept our Terms of Use and Privacy Policy, and agree to sign up for the BioPharma Dive newsletter (you can unsubscribe at any time). You also agree to having your information shared with our sponsor.
I want to receive information about Nebius products and events. I can unsubscribe at any time.